Depletion of pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras

Onkologie

Volumn 34, Issue 10, 2011, Pages 526-531

  Zhang, Quan Le ^a   Tian, De An ^b   Xu, Xiang Jiang ^a  

^a Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine of Hebei Province   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Oncogene; Pokemon; Tumor

Indexed keywords

BETA CATENIN; ERYTHROID KRUPPEL LIKE FACTOR; POK ERYTHROID MYELOID ONTOGENIC FACTOR; RAS PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER TISSUE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR GENE; TUMOR VOLUME; WESTERN BLOTTING;

APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HEP G2 CELLS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR BURDEN;

EID: 80054055032     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000332141     Document Type: Article

References (10)

1. Maeda T, Hobbs RM, Merghoub T, et al.: Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005;433:278-285.
2. Maeda T, Hobbs RM, Pandolfi PP: The transcription factor pokemon: a new key player in cancer pathogenesis. Cancer Res 2005;65:8575-8577.
3. Schubot FD, Tropea JE, Waugh DS: Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem Biophys Res Commun 2006;351:1-6. (Pubitemid 44635398)
4. Kelly KF, Daniel JM: POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol 2006;16:578-587. (Pubitemid 44636217)
5. Aqrawal A, Yang J, Murphy RF, et al.: Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer. Exp Mol Pathol 2006;81:115-122. (Pubitemid 44717514)
6. Apostolopoulou K, Pateras IS, Evangelou K, et al:. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 2007;213:294-302. (Pubitemid 350074019)
7. Costoya JA: Functional analysis of the role of POK transcriptional repressors. Brief Funct Genomic Proteomic 2007;6:8-18. (Pubitemid 351721044)
8. Laudes M, Christodoulides C, Sewter C, et al.: Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J Biol Chem 2004;279:11711-11718. (Pubitemid 38401675)
9. Liu CJ, Prazak L, Fajardo M, et al.: Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J Biol Chem 2004;279:47081-47091. (Pubitemid 39518364)
10. Kukita A, Kukita T, Ouchida M, et al.: Osteoclastderived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 1999;94:1987-1997. (Pubitemid 29430415)